title: Colchicine therapy for hepatic murine schistosomal fibrosis: image analysis and serological study.
abstract: Colchicine in a dose of 200 micrograms kg body weight/day (5 days/week) was administered to groups of Schistosoma mansoni infected mice 12 weeks post infection, either alone or following previous praziquantel therapy at the 8th week of infection. Certain groups received colchicine for 6 weeks and others received it for 10 weeks. Colchicine alone did not significantly change the light microscopic appearance of schistosomal liver fibrosis, or hepatic collagen content estimated histomorphometrically, and did not reduce the elevated IL-2 serum level. Colchicine induced hepatic injury consisted of intense inflammatory reaction in granuloma and portal tracts, hepatocytic degeneration, and elevation of serum AST and ALT levels. Colchicine seemed to postpone granulomatous reaction healing and collagen deposition rather than inhibiting collagen formation or degrading it. Colchicine inhibited proliferation of hepatocytes of infected mice by expanding G2-M phases of cell cycle, thus reduced Ag NOR count and raised cell ploidy and cyclic AMP serum level. Subsidence of schistosomal infection by praziquantel prior to colchicine therapy greatly reduced inflammatory cellular reaction, significantly diminished hepatic collagen deposition and serum IL-2 level, minimized the elevated nuclear ploidy and cyclic AMP serum level that followed colchicine therapy when administered alone.
authors.affiliation: Department of Pathology, Theodor Bilharz Research Institute, Imbaba, Giza, Egypt.
authors.forename: A A
authors.initials: AA
authors.lastname: Badawy
authors.forename: N M
authors.initials: NM
authors.lastname: el-Badrawy
authors.forename: M M
authors.initials: MM
authors.lastname: Hassan
authors.forename: F A
authors.initials: FA
authors.lastname: Ebeid
mesh_terms: D000818:Animals; D002453:Cell Cycle / Q000187:drug effects; D003078:Colchicine / Q000627:therapeutic use*; D003094:Collagen / Q000378:metabolism; D004247:DNA / Q000032:analysis; D005260:Female; D007091:Image Processing, Computer-Assisted; D007376:Interleukin-2 / Q000097:blood; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D051379:Mice; D009697:Nucleolus Organizer Region / Q000187:drug effects; D012555:Schistosomiasis mansoni / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology
chemical_list: D007376:Interleukin-2; D003094:Collagen; D004247:DNA; D003078:Colchicine